Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (621-630 of 664) with videos related to

Pageof 67
Sort By:
Journal for Immunotherapy of Cancer|July 28, 2021
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancerAlexander Stein, Donjete Simnica, Christoph Schultheiß, et al.
Annals of Hematology|December 28, 2022
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapyPiroska Klement, Walter Fiedler, Razif Gabdoulline, et al.
Journal of Cancer Research and Clinical Oncology|March 11, 2017
Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancerSimon Dulz, Niels H Asselborn, Klaus-Peter Dieckmann, et al.
Blood Cancer Journal|July 30, 2025
Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvementMaximilian J Steinhardt, Christoph Schaefers, Lisa B Leypoldt, et al.
Frontiers in Oncology|January 6, 2023
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancerJoseph Tintelnot, Inka Ristow, Markus Sauer, et al.
Molecular Pharmaceutics|September 21, 2023
Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro ModelsSergey A Dyshlovoy, Jessica Hauschild, Simone Venz, et al.
International Journal of Cancer|January 30, 2019
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trialMelanie Janning, Volkmar Müller, Eik Vettorazzi, et al.
Annals of Internal Medicine|May 7, 2020
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort StudyDominic Wichmann, Jan-Peter Sperhake, Marc Lütgehetmann, et al.
Oncotarget|September 15, 2016
Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancerSergey A Dyshlovoy, Katharina Otte, Winfried H Alsdorf, et al.
Future Oncology (London, England)|September 30, 2024
Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myelomaLisa B Leypoldt, Diana Tichy, Britta Besemer, et al.
Pageof 67

Showing results (621-630 of 664) with videos related to

Sort By:
Pageof 67
Journal for Immunotherapy of Cancer|July 28, 2021
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancerAlexander Stein, Donjete Simnica, Christoph Schultheiß, et al.
Annals of Hematology|December 28, 2022
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapyPiroska Klement, Walter Fiedler, Razif Gabdoulline, et al.
Journal of Cancer Research and Clinical Oncology|March 11, 2017
Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancerSimon Dulz, Niels H Asselborn, Klaus-Peter Dieckmann, et al.
Blood Cancer Journal|July 30, 2025
Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvementMaximilian J Steinhardt, Christoph Schaefers, Lisa B Leypoldt, et al.
Frontiers in Oncology|January 6, 2023
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancerJoseph Tintelnot, Inka Ristow, Markus Sauer, et al.
Molecular Pharmaceutics|September 21, 2023
Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro ModelsSergey A Dyshlovoy, Jessica Hauschild, Simone Venz, et al.
International Journal of Cancer|January 30, 2019
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trialMelanie Janning, Volkmar Müller, Eik Vettorazzi, et al.
Annals of Internal Medicine|May 7, 2020
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort StudyDominic Wichmann, Jan-Peter Sperhake, Marc Lütgehetmann, et al.
Oncotarget|September 15, 2016
Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancerSergey A Dyshlovoy, Katharina Otte, Winfried H Alsdorf, et al.
Future Oncology (London, England)|September 30, 2024
Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myelomaLisa B Leypoldt, Diana Tichy, Britta Besemer, et al.
Pageof 67